Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
about
Bisphosphonates for advanced prostate cancerThe osteocyte as a therapeutic target in the treatment of osteoporosisRisk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRNDrug holiday as a prognostic factor of medication-related osteonecrosis of the jaw.Monostotic fibrous dysplasia involving occipital bone: a case report and review of literaturePhosphate: known and potential roles during development and regeneration of teeth and supporting structures.SYNTHESIS OF SYMMETRICAL METHYLENEBIS(ALKYL HYDROGEN PHOSPHONATES) BY SELECTIVE CLEAVAGE OF METHYLENEBIS(DIALKYL PHOSPHONATES) WITH MORPHOLINE.Osteonecrosis of the jaw and bisphosphonates: a comparison with white phosphorus, radium, and osteopetrosis.Evaluation of socket healing in patients undergoing bisphosphonate therapy: experience of a single Institution.Genetics of the bone response to bisphosphonate treatmentsNew Target Sites for Treatment of Osteoporosis.Bone-seeking agents for the treatment of bone disorders.Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia.Dental risk factors for osteonecrosis of the jaws: a CONDOR case-control study.Bisphosphonates for advanced prostate cancer.Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment.Vascular endothelial growth factor genetic polymorphisms and haplotypes in female patients with bisphosphonate-related osteonecrosis of the jaws.Microwave-driven Synthesis of Iron Oxide Nanoparticles for Fast Detection of Atherosclerosis
P2860
Q24244161-4872749D-F282-48EF-ACE1-6ACB0D298EB4Q27009129-BD5C1981-C857-4BB2-A0FD-7E5251404154Q34164223-F03682A4-964C-4F9E-856E-D335DA8A3247Q34441331-EB63F8A8-F43E-49A6-89B2-5D05657D1925Q35123755-4179F380-A423-41B7-B009-9DF60D742777Q35920063-9C97E277-0532-4BAB-9E8A-9868DBCEC2D6Q36419670-FA971392-94E7-4249-AE22-65A8E6673E80Q36939499-D8F5DF60-A65A-4738-8CDC-F9CC81FB6A77Q37063582-D398ABBF-F968-4E61-8610-9E16489540E6Q37430395-2F1CCE83-6673-4E1A-AB65-231872E14596Q39151180-CBDB3B72-F6A3-4A19-8D3D-FCD6A971756CQ39356298-2C063F91-110C-4F67-A0F7-C23240D0CE23Q39370281-4EB7E739-0A7D-468F-9C64-D3196F94606CQ41291896-55F7F76D-253D-4F0E-B89B-050D9797E848Q47248454-262A4016-6302-4417-87EA-565C93A6AEC6Q47341487-86021147-F76B-4118-AE5E-E7FD8DEC0138Q51514887-17510E20-F36A-4485-9698-6501983A402FQ58885355-82BE54AA-B51A-4978-A517-543F970829F5
P2860
Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
@ast
Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
@en
type
label
Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
@ast
Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
@en
prefLabel
Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
@ast
Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
@en
P1476
Treatment of bone diseases with bisphosphonates, excluding osteoporosis.
@en
P2093
Devogelaer JP
P304
P356
10.1097/00002281-200007000-00017
P577
2000-07-01T00:00:00Z